In mouse models of oncogenic Kras-induced glioma, tumor cells have increased expression of both phosphorylated ERK and phosphorylated AKT [7,20], indicating activation of the canonical Ras and PI3K-AKT pathways. The gene discussed is KRAS; the disease is central nervous system cancer.